The 74 tumor cores with high EBER+ NPC cells were further stratified into three groups based on the frequency of EBER+ NPC cells expressing CD137: low (n = 43), intermediate (n = 25), and high (n = 6) groups. The gene discussed is TNFRSF9; the disease is nasopharyngeal carcinoma.